Bio-Rad Laboratories Inc (NYSE: BIO) stock enjoyed a major increase of 13.0% on 4/9/25. The shares closed at $249.17. Moreover, this advance was accompanied by unusually high trading volume at 151% of normal. The stock has risen 3.8% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Bio-Rad Laboratories has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Bio-Rad Laboratories has a neutral Appreciation Score of 56 but a poor Power Rating of 26, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment